Markets:

Overview

News

Currencies

International

Treasuries

Thermo Fisher Scientific (NY:TMO)

611.20 +18.69 (+3.15%)

Official Closing Price Updated: 4:10 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Thermo Fisher (TMO): Buy, Sell, or Hold Post Q3 Earnings?

January 04, 2026

What a time it’s been for Thermo Fisher. In the past six months alone, the company’s stock price has increased by a massive 41.4%, reaching $591.90 per share. This was partly thanks to its solid...

Via StockStory

3 Low-Volatility Stocks That Fall Short

December 28, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Via StockStory

Sector Rotation: 2 Smart Money Moves for 2026 ↗

December 26, 2025

Via MarketBeat

2 S&P 500 Stocks Worth Investigating and 1 We Avoid

December 23, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Q3 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

December 21, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Thermo Fisher (NYSE:TMO) and its peers.

Via StockStory

Topics Economy

3 Mega-Cap Stocks with Warning Signs

December 18, 2025

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works...

Via StockStory

3 Profitable Stocks Walking a Fine Line

December 14, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

Topics Economy

Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health

December 09, 2025

New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend...

Via MarketMinute

Gapping S&P500 stocks in Thursday's session ↗

December 04, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds

November 24, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value

November 19, 2025

SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has...

Via MarketMinute

Topics Artificial Intelligence Economy Regulatory Compliance

Institutions Love These 3 Companies, Should You As Well? ↗

November 19, 2025

Via MarketBeat

These 3 Stocks Are Using Buybacks to Signal Market Confidence ↗

November 18, 2025

Via MarketBeat

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' ↗

November 18, 2025

Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.

Via Benzinga

Topics ETFs

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Topics ETFs

Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' ↗

November 14, 2025

Kimberly-Clark is still "oversold after the Kenvue announcement," Jenny Van Leeuwen Harrington says, citing its 5% dividend yield.

Via Benzinga

Thermo Fisher Scientific Reinforces Investor Confidence with Latest Quarterly Dividend Declaration

November 06, 2025

Waltham, MA – November 6, 2025 – Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific instrumentation, laboratory services, and diagnostic solutions, today announced its latest...

Via MarketMinute

Topics Artificial Intelligence Economy Retirement

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗

November 04, 2025

Via Benzinga

Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence

October 29, 2025

Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

How Is The Market Feeling About Thermo Fisher Scientific Inc? ↗

October 29, 2025

Via Benzinga

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities ↗

October 29, 2025

Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and digital drug development capabilities.

Via Benzinga

Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal ↗

October 29, 2025

Thermo Fisher expects the acquisition to be immediately accretive to its adjusted operating margin.

Via Stocktwits

5 Revealing Analyst Questions From Thermo Fisher’s Q3 Earnings Call

October 29, 2025

Thermo Fisher's third quarter results drew a positive market response, with management attributing outperformance to robust momentum in bioproduction, analytical instruments, and clinical research...

Via StockStory

Topics Earnings

Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth ↗

October 27, 2025

Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth

Via The Motley Fool

If You Invested $1000 In Thermo Fisher Scientific Stock 10 Years Ago, You Would Have This Much Today ↗

October 23, 2025

Via Benzinga

8 Analysts Have This To Say About Thermo Fisher Scientific ↗

October 23, 2025

Via Benzinga

Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings ↗

October 23, 2025

Via Benzinga

TMO Q3 Deep Dive: New Products, Capital Deployment, and Strategic Collaborations Drive Growth

October 23, 2025

Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 4.9% year on year to $11.12 billion. Its non-GAAP profit of $5.79 per...

Via StockStory

Tech Stocks Drop, Netflix Sinks 10% On Worst Day Since 2022: What's Moving Markets Wednesday? ↗

October 22, 2025

Risk sentiment deteriorated sharply on Wednesday as a wave of disappointing earnings guidance and escalating U.S.-China trade tensions rattled investor confidence.

Via Benzinga

Topics World Trade

Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says ↗

October 22, 2025

Thermo Fisher Scientific reports Q3 2025 adjusted earnings of $5.79 per share, sales of $11.12 billion and raised its full-year guidance.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.